NASDAQ: ENLVEnlivex Therapeutics Ltd Stock Ownership - Who owns Enlivex Therapeutics?
Insider buying vs selling
Have Enlivex Therapeutics Ltd insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.
Be the first to know when ENLV insiders and whales buy or sell their stock.
ENLV Shareholders
What type of owners hold Enlivex Therapeutics Ltd stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Digital Generation Inc | 57.80% | 10,750,000 | $15.48M | Insider |
| James Crabbe | 16.91% | 3,145,600 | $4.53M | Insider |
| Adam Moore | 1.08% | 201,299 | $289.87k | Insider |
| Dan Isaacs | 1.08% | 201,299 | $289.87k | Insider |
| Renaissance Technologies LLC | 0.33% | 62,089 | $89.41k | Institution |
| Jerry S. Amato | 0.27% | 50,000 | $72.00k | Insider |
| Morgan Stanley | 0.24% | 44,460 | $64.02k | Institution |
| Susquehanna International Group LLP | 0.15% | 27,925 | $40.21k | Institution |
| William Hayward Mitchell | 0.08% | 14,500 | $20.88k | Insider |
| Edmond De Rothschild Holding Sa | 0.07% | 13,000 | $18.72k | Institution |
ENLV vs Biotech Stocks
Enlivex Therapeutics Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.